There are big cuts to US AIDS prevention that may result in HIV research being axed

AIDS in the First Trump Administration: Implications for the United States and the Security and Security of the Affordable Treatment Act (AIDS Prevention)

The remaining programme is going to continue the work to end HIV according to a person familiar with the changes at HHS. That was a big priority of President Trump during the first administration.”

In an email to The Verge, HHS press secretary Vianca Rodriguez Feliciano maintains that “ongoing critical public health efforts will remain a top priority and will not be impacted by this administrative realignment.”

Drastic “reductions in force” are upending agencies within the Department of Health and Human Services (HHS), including the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA).

When news of the layoffs hit, “I got tears in my eyes,” says Carl Schmid, who co-chaired the Presidential Advisory Council on HIV/AIDS during the first Trump administration. These are people who have spent their lives trying to end HIV.

Sara Zeigler, who worked for 20 years as the CDC’s associate director for policy until May 2022, fears that the lack of expertise of workers assuming other programmes’ activities will undermine US HIV prevention efforts. “It’s just an additional tragedy on top of tragedy,” Zeigler says. That will cause people to die, and will cause significant increases to our costs throughout the country.

The Science of the FDA: When Joe Biden and Barack Obama Made Sense of “Unnecessary, Preventable Death”

It’s a senior science reporter with more than a decade of experience. She hosts a show named “Hell or High Water: When Disaster hits Home”, which is hosted by Vox Media.

The Trump administration tried to reduce the number of federal workforce jobs by notifying thousands of people who worked at the CDC. Top officials were among those either put on administrative leave, laid off, or reassigned to remote roles, the Washington Post reports.

A doctor at the University of Chicago says they are going to have patients die. “Unnecessary, preventable death.”

The director of the FDA’s Center for Biologics Evaluation and Research resigned, saying that it has become obvious that truth and transparency isn’t desired by the Secretary, but rather he wants confirmation of his misinformation and lies.

“The FDA as we’ve known it is finished, with most of the leaders with institutional knowledge and a deep understanding of product development and safety no longer employed,” Robert Califf, FDA commissioner under Joe Biden and Barack Obama, wrote on LinkedIn today.